Stay updated on PK and Safety of Omalizumab in Healthy Subjects Clinical Trial

Sign up to get notified when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a completed Phase 1 omalizumab comparison study is displayed, with study details, participant criteria, Australian locations, and pharmacokinetic and safety outcome measures.
    Difference
    47%
    Check dated 2026-11-09T13:51:51.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer's revision identifier changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:58:08.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition was added, linking to updates and FAQs and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T15:13:34.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:51:31.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:52:53.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now shown, and a large set of study documents and related items in the Study Documents section were removed. The update changes what materials are readily available for review and verification of the study record.
    Difference
    18%
    Check dated 2026-09-21T22:49:14.000Z thumbnail image

Stay in the know with updates to PK and Safety of Omalizumab in Healthy Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.